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Abstract
Objectives
To characterize the microbiological, molecular and epidemiological data of an outbreak of
carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital in Mexico.
Methods
From September 2014 to July 2015, all CRE clinical isolates recovered during an outbreak
in the Hospital Civil "Fray Antonio Alcalde" in Jalisco, Mexico were screened for antimicro-
bial susceptibility, carbapenemase production, carbapenemase-encoding genes, and plas-
mid profiles. Horizontal transfer of imipenem resistance; and clonal diversity by pulsed-field
gel electrophoresis (PFGE) and multilocus sequence typing (MLST); as well as biofilm pro-
duction and the presence of 14 virulence genes were analyzed in selected isolates.
Results
Fifty-two carbapenem-resistant isolates corresponding to 5 species were detected, i.e.,
Klebsiella pneumoniae (n = 46), Enterobacter cloacae (n = 3), Escherichia coli (n = 1), Provi-
dencia rettgeri (n = 1) and Citrobacter freundii (n = 1) with carbapenemase encoding genes
blaNDM-1 (n = 48), blaVIM (n = 3), blaIMP (n = 1) and blaKPC (n = 1) detected in these isolates.
The blaNDM-1 gene was detected in plasmids from 130- to 170-kb in K. pneumoniae (n =
46); E. cloacae (n = 3), E. coli (n = 1) and P. rettgeri (n = 1). The transfer of plasmids harbor-
ing the blaNDM-1 gene was obtained in eight transconjugants. One plasmid restriction pattern
was detected, with the blaNDM-1 identified in different restriction fragments.
Predominant clone A of K. pneumoniae isolates archived 28/46 (60%) isolates and
belongs to ST392. Besides, ST307, ST309, ST846, ST2399, and ST2400 were detected for
K. pneumoniae; as well as E. cloacae ST182 and E. coli ST10.
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The fimA and uge genes were more likely to be identified in K. pneumoniae carbapenem-
susceptible isolates (p = <0.001) and biofilm production was more liable to be observed in
carbapenem-resistant isolates (p = <0.05).
Conclusions
Four Enterobacteriaceae species harboring the blaNDM-1 gene were detected in a nosoco-
mial outbreak in Mexico; horizontal transfer and strain transmission were demonstrated for
the blaNDM-1 gene. Given the variation in the size of the plasmid harboring blaNDM-1, complex
rearrangements must also be occurring.
Introduction
Nosocomial infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are of partic-
ular concern since they can spread rapidly worldwide, and few treatment options remain avail-
able for these diseases [1]. Several carbapenem resistance mechanisms have been described in
bacteria, and one of the most important in Gram-negative species is the production of carba-
penemase enzymes [1,2]. A high diversity of carbapenemases has been reported in Enterobac-
teriaceae, including the Ambler class A blaKPC, class B metallo-β-lactamases, blaVIM, blaIMP,
and blaNDM, and class D carbapenemase blaOXA-48 type [3]. The blaNDM-1 gene is located most
frequently on large conjugative plasmids of several incompatibility groups. These plasmids
also harbor genes conferring resistance to almost all antibiotics that are used to treat entero-
bacterial infections [2,3].
In Mexico, the first report of blaNDM-1 was identified in Providencia rettgeri [4], and it was
subsequently identified in a Klebsiella pneumoniae pediatric isolate [5]. Furthermore, horizon-
tal transfer and clonal dissemination have been reported in this country, in an outbreak caused
by K. pneumoniae, Escherichia coli and Enterobacter cloacae strains harboring a 101-kb IncFII
plasmid carrying the blaNDM-1 gene [6].
The analysis of sixteen NDM-1-producing enterobacterial isolates from eight countries
showed that the spread of the blaNDM-1 gene is not related to specific clones, specific plasmids,
or a single genetic structure [3,7]. The rapid and successful spread of carbapenem-resistant
NDM-1-positive organisms may be associated with other antibiotic resistance mechanisms;
however, the coexistence of multidrug resistance and virulence mechanisms has also been pro-
posed [8].
Several virulence factors have been described in K. pneumoniae, including adhesins, capsu-
lar serotype, iron-scavenging systems, lipopolysaccharide, and biofilm production [9]. The
aim of this study was to characterize the epidemiological, microbiological and molecular data
of an outbreak of CRE in a tertiary-care hospital in Mexico.
Materials and methods
Hospital setting and recognition of outbreak
This study was performed in the Hospital Civil de Guadalajara “Fray Antonio Alcalde” in
Jalisco, Mexico. This hospital is an 899-bed tertiary-care teaching hospital located in Guadala-
jara, the second largest city in Mexico. This hospital provides care to adult and pediatric
patients in 31 wards situated among three connected buildings.
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In September 2014, resistance to carbapenem was detected in five clinical isolates of Entero-
bacteriaceae in the Laboratory of Bacteriology. The infection control department was alerted,
and from there all isolated Enterobacteriaceae between September 2014 and July 2015 were col-
lected for analysis. Before September 2014, we had no carbapenem-resistant isolates.
Ethics statement
The local ethics committee (Comite´ de E´tica en Investigacio´n del Antiguo Hospital Civil de
Guadalajara “Fray Antonio Alcalde,” Jalisco, Mexico) approved this study with reference num-
ber 003/16. Informed consent was waived by the Ethics Committee because no intervention
was involved and no patients identifying information was included.
Clinical isolates and patients
Enterobacteriaceae species were identified by Matrix-Assisted Laser Desorption Ionization-
Time-of-Flight Mass Spectrometry (MALDI-TOF MS) using the Bruker Biotyper (Bruker Dal-
tonics, Germany) as described previously [10].
Drug susceptibility was performed for all isolates using the VITEK automated system and
confirmed by the broth microdilution method. Guidelines of the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) version 6.0 were used for colistin and tigecy-
cline [11]. Guidelines of the CLSI were used for amikacin, gentamicin, ertapenem, imipenem,
meropenem, ceftriaxone, trimethoprim/sulfamethoxazole, aztreonam, ampicillin, ciprofloxa-
cin, fosfomycin, chloramphenicol [12]. Multidrug-Resistance (MDR) was defined as non-sus-
ceptibility to one or more agents of at least three different antibiotic classes [13].
Carbapenem-resistant isolates were screened to detect carbapenemase production using the
CarbaNP test [12], and to detect the carbapenemase-encoding genes for blaKPC, MBL (blaVIM,
blaIMP, and blaNDM) and blaOXA-48 by PCR [14–16]. PCR products were sequenced using the
chain termination method with a Big-Dye Terminator kit (Applied Biosystems Foster City,
CA) and ABI PRISM 3130 (Applied Biosystems). ESBL encoding genes (blaTEM, blaSHV,
blaCTX-M and blaCYM), mcr-1 and mcr-2 genes were screened by PCR [17–19].
We recovered demographic and clinical data from patients infected with a carbapenem
resistant-carbapenemase producer isolates. From each enterobacterial species, one isolate per
patient was analyzed.
Plasmid analysis
Plasmid profiles were obtained from all carbapenem-resistant isolates according to the method
described by Kieser [20]. In isolates that presented different plasmid profile according to Kie-
ser method, the S1 nuclease assay was performed [21].
Horizontal transfer of carbapenem resistance by bacterial conjugation with E. coli J53-2 as
the recipient strain was performed by liquid and solid-phase mating as described [22,23] in
isolates that presented a different plasmid profile according to S1 nuclease assay. Transconju-
gants were selected on Luria-Bertani (LB) agar supplemented with rifampin (100 μg/ml) plus
imipenem (2 μg/ml) when the conjugation was unsuccessful the assay was performed in LB
agar supplemented with rifampin (100 μg/ml) plus cefoxitin (30 μg/ml). Enzymatic digestion
with HinIII (Invitrogen, California, USA) was performed in transconjugants with only one
plasmid present. The incompatibility groups were detected by PCR replicon typing in these
isolates [24].
Additionally, Southern hybridization with a non-radioactive probe (ECL direct nucleic acid
labeling and detection system; GE Healthcare, Piscataway, NJ) of the blaNDM-1 gene was per-
formed in transconjugants and blaNDM-1 positive isolates.
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Clonal diversity studies
Clonal diversity was performed by pulsed-field gel electrophoresis (PFGE) and Multilocus
sequence typing (MLST) analysis of selected isolates. For PFGE, chromosomal DNA was prepared
using the methodology described by Kaufmann [25] with some modifications. Chromosomal
DNA from the isolates was digested with 10 U of XbaI (Takara Bio Inc., Shiga, Japan) with follow-
ing conditions: temperature of 14˚C, the voltage of 6 V/cm, run time of 23 h, and switch time of
1–30 s. PFGE patterns were analyzed visually, and when the restriction patterns presented 100%
similarity, the isolates were classified as a clone. When two or three difference in the restriction
pattern were detected the isolates were considered as subtypes as suggested by Tenover et al. [26].
MLST was performed on selected isolates harboring blaNDM-1 gene according to species,
PFGE pattern and plasmid analysis using the MLST websites: http://bigsdb.pasteur.fr, http://
mlst.warwick.ac.uk and http://pubmlst.org [27–29].
Virulence factors
Detection of genes encoding virulence factors and determination of biofilm formation were
conducted only for the K. pneumoniae isolates. For a comparison of virulence factors of carba-
penem-resistant (blaNDM-1 positive) and carbapenem-susceptible isolates, a group of twenty-
three carbapenem-susceptible isolates was randomly selected for analysis. The susceptible iso-
lates were obtained in the same period of the carbapenem-resistant isolates (September
2014-June 2015) and were collected from similar specimens and hospital wards to carbape-
nem-resistant isolates.
Virulence genes from K. pneumoniae [serotypes K1 and K2, rmpA, rmpA2 (regulator of
mucoid phenotype), uge (uridine diphosphate galacturonate-4 epimerase), ureA (urease), entB
(enterobactin), iroB (salmochelin), irp2 (yersiniabactin), iucA (aerobactin), fimA (fimbrial),
fimH (fimbrial), mrkA (fimbrial), and mrkD (fimbrial)] were screened by PCR [30].
Furthermore, semi-quantitative determination of biofilm formation was performed in these
isolates (both carbapenem-resistant and carbapenem susceptible) by crystal violet staining as pre-
viously described by Bandeira et al., with modifications described by Burmølle et al. [9,31]. The
biofilm index (OD595/OD600) was used to normalize the amount of biofilm formed to the total
cell content of each sample tested. The biofilm production was classified using the biofilm index
as non-adherent (<0.90), weakly adherent (>0.90–<1.20) and strongly adherent (>1.20) The
cut-off values were defined according to a comparison in the classification with others methodolo-
gies previously reported [32]. Staphylococcus aureus ATCC 29213 (a high biofilm producer) and
E. coli ATCC 25922 (a low biofilm producer) were used as quality control organisms.
Statistical analysis
The similarity coefficients were generated from a similarity matrix calculated using the Jac-
card’s coefficient.
Percentages of biofilm production and from each virulence factor were compared using
Mann-Whitney test. A P value less than 0.05 was considered statistically significant. Statistical
analysis was performed in the SPSS Statistics 22 software (IBM Corporation, Somers, NY, USA).
Results
Species and resistance genes
During the eleven months of study, 3044 isolates of Enterobacteriaceae were recovered; 86/
3044 (2.83%) of them were carbapenem-resistant and carbapenemase-producers. From each
enterobacterial species, one isolate per patient was selected for the study (52 isolates).
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Five species were found to produce a carbapenemase: K. pneumoniae (n = 46, 88%), E. cloa-
cae (n = 3, 6%), E. coli, P. rettgeri and Citrobacter freundii (n = 1, 2% each).
The blaNDM-1 gene was detected in 48/52 (92.3%) isolates belonging to K. pneumoniae
(n = 43, 90%), E. cloacae (n = 3, 6%), E. coli and P. rettgeri (n = 1, 2%, each).
The blaVIM gene was detected in 3/52 (5.6%) isolates belonging to K. pneumoniae (n = 2)
and C. freundii (n = 1). The blaKPC gene was detected in one isolate of K. pneumoniae, and the
P. rettgeri isolate harbored two carbapenemase genes (blaNDM-1 and blaIMP). The blaOXA-48
gene was not detected in any of the isolates.
The first carbapenem-resistance isolate was an NDM-1-producing K. pneumoniae (Fig 1).
Isolates harboring the blaNDM-1 gene were detected throughout the study.
The blaSHV gene was detected in 45/52 (86.5%) isolates, the blaCTX-M gene was detected in
39/52 (75%) isolates, the blaTEM gene was detected in 30/52 (57.7%) isolates and, blaCYM, mcr-
1, and mcr-2 genes were not detected in any isolate.
Demographic and clinical data
The 52 isolates were recovered from 51 patients, with one of them was co-infected with two
blaNDM-1 species (E. cloacae and E. coli). The mean age was 44 (0–81) years; 66.7% were male,
and the mean length of stay (LOS) before positive culture was 26 (range 3–76) days. Clinical
characteristics and outcome of the patients are shown in S1 Table. The most frequent cause of
hospitalization was brain injury (20% of patients), followed by lower respiratory tract infection
(15%), chronic renal failure, and burn injuries (7.5% each).
Antimicrobial susceptibility patterns
Regarding all the 52 CRE, resistance to ampicillin (100%), ceftriaxone (100%), trimethoprim/
sulfamethoxazole (98%), ertapenem (96%), fosfomycin (92%), meropenem (90%), imipenem
Fig 1. Temporal distribution of recovered carbapenem-resistant Enterobacteriaceae isolates from September 2014 to July 2015. Grey squares
represent blaNDM-1; black squares represent blaVIM; white squares represent blaKPC; grey and lined squares represent the blaNDM-1/blaIMP. K represents K.
pneumoniae; E represents E. cloacae; Ec represents E. coli; C represents C. freundii; and P represents P. rettgeri.
https://doi.org/10.1371/journal.pone.0179651.g001
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(88%), ciprofloxacin (87%), gentamicin (83%), amikacin (79%), and aztreonam (73%) was
detected. Lower resistance to chloramphenicol (52%), tigecycline (19%), and colistin (4%) was
observed. The two colistin-resistant isolates corresponded to K. pneumoniae positives for
blaNDM-1 and the patients were treated with carbapenems and colistin before the CRE isola-
tion, and after the CRE isolation, a combined therapy of colistin and tigecycline was used.
From the CRE isolates, 51/52 (98%) were classified as MDR and the single non-MDR isolate
corresponded to C. freundii positive for blaVIM carbapenemase. The C. freundii isolate was sus-
ceptible to the three carbapenems tested by microdilution but resistant to meropenem and
ertapenem using the VITEK system. The other K. pneumoniae isolates that harbored blaVIM
presented only resistance to imipenem.
Considering the E. cloacae isolates, all were resistant to all antibiotics tested except for tige-
cycline (one strain resistant).
Regarding only the NDM-1-producing K. pneumoniae, a high drug resistance was detected.
The minimum inhibitory concentration (MIC) range, MIC90, and MIC50, as well as the per-
centage of resistant and susceptible isolates to each of the antimicrobial agents tested, are indi-
cated in Table 1.
Plasmid pattern, hybridization and transfer of carbapenem resistance
The plasmid profiles of all the 52 CRE clinical isolates harbored between one and five plasmids
with sizes of 40 to170 kb. The plasmid profile of NDM-harboring Enterobacteriaceae isolates
(n = 48) was heterogeneous with 15 different sizes of plasmids according to Kieser method and
eight different sizes by S1 nuclease assay.
Characteristics of 15 representative isolates of Enterobacteriaceae harboring blaNDM-1 are
shown in Table 2. Thirteen isolates (K. pneumoniae, n = 11; and E. cloacae, n = 2) were success-
ful in transfer the resistance with eight transconjugants receiving only one plasmid, (from
130 to 150 kb) and contained the blaNDM-1 gene. Enzymatic digestion revealed one unique
Table 1. Antimicrobial susceptibility of blaNDM-1 producing K. pneumoniae isolates (n = 43).
Antibiotic MIC (mg/L) Isolates n (%)
Range 50% 90% Susceptible Resistant
Amikacin 4– 128  128  128 6 (14) 37 (86)
Gentamicin 1- 32  32  32 5 (11.6) 38 (88.4)
Ertapenem 4– 128 16 32 0 (0) 43 (100)
Imipenem 2–256 8 16 0 (0) 38 (88.4)
Meropenem 2–256 8 16 1 (2.3) 40 (93)
Ceftriaxone  64  64  64 0 (0) 43 (100)
Trimethoprim/ Sulfamethoxazole 8/152–16/304 16/304 16/304 0 (0) 43 (100)
Aztreonam 2-128 16 32 7 (16.3) 32 (74.4)
Ampicillin 64-128  128  128 0 (0) 43 (100)
Ciprofloxacin 0.5–16  16  16 3 (7) 38 (88.4)
Fosfomycin 256–512 512  512 0 (0) 43 (100)
Chloramphenicol 4-128 16 128 6 (14) 20 (46.5)
Colistin 0.5-16 0.5 2 41 (95.3) 2 (4.7)
Tigecycline 0.5–8 2 4 7 (16.3) 9 (21)
Classification of resistance and susceptibility to amikacin, gentamicin, ertapenem, imipenem, meropenem, ceftriaxone, trimethoprim/sulfamethoxazole,
aztreonam, ampicillin, ciprofloxacin, fosfomycin, chloramphenicol was based on CLSI interpretive criteria. Classification of resistance and susceptibility to
colistin and tigecycline was based on EUCAST interpretative criteria.
https://doi.org/10.1371/journal.pone.0179651.t001
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restriction pattern, with the blaNDM-1 gene present on a>1.5 kb fragment in seven transconju-
gants and a smaller 1.0 Kb fragment in one transconjugant (Fig 2). The IncFIIk and IncFIIy
incompatibility groups were identified in the eight transconjugants and the E. coli isolate that
presented a single plasmid, in 88.9% (8/9) and 22.2% (2/9) of the plasmids, respectively.
The Southern hybridization experiments showed the presence of the blaNDM-1 gene in four
different plasmids, with sizes from 130 to 170 kb. One blaNDM-1 gene copy was identified in
Table 2. Characteristics of representative isolates of Enterobacteriaceae harboring blaNDM-1.
Clinical isolate data
Strain ID 14–
3335
14–
3337
14–
3338
14–
3423
14–
3424
14–
3425
14–
3442
15–
0026*
15–
1880
15–
1327*
15–
1363
15–
1362
15–1372 15–
1887
15–
1941
Species K. pn K. pn K. pn K. pn K. pn K. pn E. cl E. cl K. pn E. coli K. pn K. pn K. pn K. pn P. re
Susceptibility. MIC mg/L (Interpretation)
AMP >128 64 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128 >128
CRO >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64 >64
ETP >128 4 8 16 32 16 32 128 32 8 32 32 16 16 4
IMP 256 8 8 8 8 8 8 32 256 4 8 4 8 8 4
MEM 256 2 4 8 16 8 16 16 128 4 16 8 4 8 8
ATM 16 <2 8 16 16 16 16 16 16 8 16 <2 16 16 <2
SXT 16/304 16/304 16/304 16/304 16/304 16/304 16/304 16/304 16/
304
16/
304
16/304 16/
304
16/304 16/
304
16/
304
GEN >32 <1 16 >32 >32 >32 >32 >32 >32 >32 >32 <1 >32 >32 <1
AMK >128 <4 16 >128 >128 >128 >128 >128 128 8 >128 16 >128 >128 16
CIP >16 <0.5 2 >16 >16 >16 >16 >16 >16 2 >16 8 >16 >16 16
FOF >512 512 256 512 512 512 512 >512 >512 32 >512 256 512 >512 128
CHL >128 <4 16 32 16 16 >128 >128 32 >128 128 64 32 32 128
TGC 2 <0.5 1 2 2 2 1 <0.5 <0.5 <0.5 2 2 2 8 1
CST <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 2 <0.5 <0.5 >16
Molecular characterization
Clone A
(n = 28)
D
(n = 1)
E
(n = 1)
A1
(n = 2)
A2
(n = 1)
A
(n = 28)
A1
(n = 1)
A
(n = 2)
A5
(n = 1)
N/A A3
(n = 2)
G
(n = 1)
A4
(n = 1)
A6
(n = 1)
N/A
ST 392 309 846 307 N/D 392 182 N/D N/D 10 N/D 2400 N/D N/D N/A
Plasmid profile
by Kieser (No.
of isolates)
130,
160,
165
(21)
130,
145,
155 (1)
130,
145,
155 (1)
130,
150,
160,
170 (1)
130,
162,
166 (3)
130,
164,
166 (7)
135,
142,
150 (1)
130,
142,
150 (2)
130,
162,
166
(1)
140
(1)
70, 78,
130,
142,
166 (2)
160,
170
(4)
130,163,
166 (1)
130,
163,
166
(1)
128,
165
(1)
Plasmid profile
by S1 nuclease
assay
82 82, 90,
96
52, 77,
90, 96
82 82, 90,
96
82 82, 86,
117,
122
82,
100,
117,
142
82 77 82,
102,
133,
142
82 82 82 59
Plasmid carrying
NDM-1 (kb)
130 130 130 130,
150
130 130 150 150 130 130 130 170 130 130 -
Positive
conjugation
(presented a
single plasmid)
Yes
(Yes)
Yes
(Yes)
Yes
(No)
Yes
(No)
Yes
(Yes)
Yes
(Yes)
Yes
(Yes)
Yes
(Yes)
Yes
(No)
No Yes
(Yes)
Yes
(No)
Yes
(Yes)
Yes
(No)
No
Incompatibility
groups
IIIk FIIy N/D N/D FIIy FIIy FIIy FIIy N/D FIIy,
FIIk
FIIy N/D FIIy N/D No
(*): same patient
K. pn: K. pneumoniae; E. cl: E. cloacae; N/D: Not detected; N/A: Not applicable; AMP: ampicillin; CRO: ceftriaxone; ETP: ertapenem; IMP: imipenem; MEM:
meropenem; ATM: aztreonam; SXT: trimethoprim/sulfamethoxazole; GEN: gentamicin; AMK: amikacin; CIP: ciprofloxacin; FOF: fosfomycin; CHL:
chloramphenicol; TGC: tigecycline; CST: colistin.
https://doi.org/10.1371/journal.pone.0179651.t002
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two different plasmids (130 and 150 kb) harbored in K. pneumoniae (14–3423) isolate. Conju-
gation was unsuccessful for the E. coli, and P. rettgeri clinical isolates. The Southern hybridiza-
tion experiment was unsuccessful for the P. rettgeri isolate.
Clonal diversity
K. pneumoniae (n = 46) and E. cloacae (n = 3) isolates were subjected to PFGE assays. Regard-
ing K. pneumoniae, 14 distinct patterns were detected. The percentage of similarity ranged
from 75% to 100%, with restriction patterns of 15–20 bands and the 60.9% (28/46) of the iso-
lates corresponding to clone A; 4.3% (2/46) to clones B and C; and 2.2% (1/46) to clones D
to H.
Clone A harbored blaNDM-1, Clone B, and F strains harbored blaVIM and blaKPC genes,
respectively. The clone A presented six subtypes (19.5%, 9/46) with two or three differences in
the restriction pattern in comparison with clone A restriction pattern.
Regarding E. cloacae isolates, they were classified as closely related with only two different
bands in the restriction pattern and are considered as subtypes. The Clone A and A1 presented
one and two isolates, respectively.
Regarding MLST assays, selected isolates were K. pneumoniae (n = 6), E. coli and E. cloacae
(n = 1 each). Regarding K. pneumoniae, only isolates harboring blaNDM-1 gene and with differ-
ent plasmid profile were selected. Four ST previously reported were detected (ST392, strain
14–3335; ST309, strain 14–3337; ST846, strain 14–3338; and ST307, strain 14–3423). Further-
more, two new ST were identified (ST2400, strain 15–1362; and ST2399, strain 15–1600). The
clone A corresponded to ST392 and was detected during the 11 months of surveillance.
E. coli (15–1327) isolate corresponded to ST10, and E. cloacae (14–3442) isolate corre-
sponded to ST182.
Fig 2. Restriction pattern and Southern hybridization of selected plasmids. (A): Restriction pattern; (B):
Southern hybridization; M: Molecular weight marker of 1.5 kb; 1: 15–1327; 2: TT 14–3442 E. cloacae; 3: TT
15–0026; 4: TT 14–3335; 5: TT 14–3337; 6: TT 14–3424; 7: TT 14–3425; 8: TT 15–1363; 9: TT 15–1372. TT
represents transconjugants; E.cl represents E. cloacae; E.c represents E. coli; and K.p. represents K.
pneumoniae.
https://doi.org/10.1371/journal.pone.0179651.g002
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Virulence factors
Virulence factors analyzed in both carbapenem-resistant and carbapenem susceptible isolates
showed that the presence of fimA and uge genes was more likely to be detected in carbapenem-
susceptible isolates (P =<0.001) (Table 3).
Regarding biofilm production, the 81.8% (54/66) of the isolates were classified as non-
adherent, 1.5% (1/66) as weakly adherent, and 16.7% (11/66) as strongly adherent. All strongly
and weakly adherent isolates were carbapenem-resistant (Table 3). Biofilm production (strong
plus weak) was found to be associated with carbapenem resistance (P =<0.05).
Discussion
In this study, we characterized the epidemiological, microbiological, and molecular data of an
outbreak of CRE in a tertiary-care hospital in western Mexico and detected that the most com-
monly gene identified was blaNDM-1 in a predominant clone A of K. pneumoniae. The presence
of only one carbapenemase type (blaNDM-1) involving K. pneumoniae, E. cloacae, and E. coli in
four epidemiologically related patients was reported in a tertiary care hospital in Mexico City
in 2015 [6], but not comprising the high number of species and isolates reported in this study.
In addition to being detected in K. pneumoniae, E. cloacae, and E. coli, the blaNDM-1 gene
has been reported in P. rettgeri isolates [4]. In this species, resistance to carbapenems is rarely
described, and when is reported, it is mainly associated with blaNDM-1 [4,33]. In this study, the P.
rettgeri isolate presented both blaNDM-1 and the blaIMP gene. The presence of blaIMP in P. rettgeri
has been reported only in Japan [34,35], and to the best of our knowledge, the presence of
blaNDM-1 and blaIMP in the same isolate has not been reported to date. Unfortunately, the P.
rettgeri isolate lost the plasmid carrying blaNDM-1 during experiments, and we were unable to
characterize it. Due to the presence of the blaIMP gene, the isolate remained carbapenem-resistant.
Of the several carbapenemases previously described worldwide, the blaKPC has been
reported as the predominant carbapenemase gene associated with CRE intrahospital infections
[36]. Nevertheless, in the recent years, blaNDM-1 gene has frequently been associated with out-
breaks, particularly with strains of K. pneumoniae and E. coli [3].
We detected more than one CRE species and multiple carbapenemases genes in the same
hospital in the same period. This diversity has been previously reported, but in countries geo-
graphically distant from Mexico (China and Kuwait) [37,38]. Because of this, our report
underscores the importance of active surveillance in all enterobacterial species.
The transfer of plasmids of 130 to170 kb carrying blaNDM-1 was demonstrated for K. pneu-
moniae, and E. cloacae and these experiments partially explain, the high dissemination inter
Table 3. Distribution of virulence factors in blaNDM-1 producing K. pneumoniae isolates and carbapenem susceptible isolates.
Group Virulence genes Biofilm production
entB iroB, K2 irp2 fimA fimH mrkA mrkD uge ureA rmpA non-adherent weakly adherent strongly adherent
CR 97.7%
(42/
43)
0%
(0/43)
60.5%
(26/
43)
18.6%
(8/43)
100%
(43/
43)
74.4%
(32/
43)
0%
(0/
43)
27.9%
(12/
43)
76.7%
(33/
43)
0%
(0/
43)
69.8%
(30/43)
4.6%
(2/43)
25.6%
(11/43)
CS 100%
(23/
23)
13%
(3/23)
47.8%
(11/
23)
65.2%
(15/
23)
95.7%
(22/
23)
100%
(23/
23)
4.3%
(1/
23)
82.6%
(19/
23)
100%
(23/
23)
8.7%
(2/
23)
100% (23/23) 0% (0/23) 0% (0/23)
P-
value
NS NS 0.467 <0.001 NS NS NS <0.001 NS NS NS NS NS
CR: Carbapenem-resistant isolates; CS: Carbapenem-susceptible isolates. NS: Not significant. iucA, K1, and rmpA2 genes were not detected.
https://doi.org/10.1371/journal.pone.0179651.t003
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and intra-species observed during the outbreak. In contrast, the inability of conjugation of E.
coli and P. rettgeri could explain the lack of dissemination of these species/plasmids during the
outbreak.
Similar restriction patterns were detected in eight plasmids of similar size (130 to150 kb)
with the blaNDM-1 gene present on the same restriction fragment in 7/8 plasmids. These results
and the different size of plasmids, strongly suggest rearrangements of plasmids during the
short period of this outbreak. Rearrangements of plasmids have been previously reported for
plasmids harboring blaVIM gene [39], but to our knowledge, rearrangements in plasmids
encoding blaNDM-1have not been previously described.
One of the most significant findings of our study was the high attributable mortality detected
for any CRE (35%, 14/40), even that this percentage was lower than previous reports (57.4%,
54/94) in clinical isolates of K. pneumoniae, E. coli, E. cloacae, C. freundii, Enterobacter aerogenes,
Klebsiella oxytoca, Raoultella ornithinolytica and Raoultella planticola obtained from 2010 to
2014 in China [37]. Furthermore, a high attributable mortality related to CRE blaNDM-1 produc-
ers was observed, regarding that lower values have been reported (28.6%, 6/21) in Kuwait for K.
pneumoniae, E. coli, E. cloacae, M. morganii and P. stuartii recovered in 2014 [38].
In our study, the 19.6% isolates were resistant to tigecycline. The high resistance detected is
a point of concern because the SENTRY Antimicrobial Surveillance Program reported in 2016
that only 2.6% of CRE from Latin America presented tigecycline resistance [40], and by these
new findings, we may infer that tigecycline resistance is increasing.
Colistin resistance was also detected (4%), and this is now a serious global menace as previ-
ous reports from India and UK showed percentages of resistance of 6% and 11%, respectively
[41]. This study is the second report of colistin-resistant Enterobacteriaceae in Mexico [42].
The molecular mechanism of resistance to colistin presented in these colistin-resistant isolates
was not acquired due to mcr gene was not detected, and additional analysis is ongoing in our
group to evaluate the mechanism(s) involved.
We detected K. pneumoniae ST307, ST392, and ST846 which have been reported as harbor-
ing blaKPC, blaOXA-48 and blaNDM-1 genes [43–45]. In contrast, the K. pneumoniae ST309
detected has not been related to carbapenemases genes.
E. cloacae ST182 harboring blaNDM-1 has been reported in Mexico and Finland [6,46]; the
ST10 of E. coli has only been reported in isolates harboring ESBL genes and not carbapene-
mase genes [47].
The combination of clonal expansion and horizontal gene transfer demonstrated in this
study has been described in Mexico, UK, and Chennai, India [6,41]. In contrast, isolates from
Haryana, India, showed an apparent clonal expansion by the demonstration of two types of
predominant plasmids [41].
In our study, we evaluated 14 virulence genes in all carbapenem-resistant and in selected
carbapenem-susceptible K. pneumoniae isolates, and we found that the frequency of virulence
genes was similar to reported when 6 K pneumoniae KPC +, ST258 were analyzed [30].
The virulence gene distribution between both groups was similar except for the fimA and
uge genes. The presence of fimA and uge genes was more frequently detected in carbapenem-
susceptible K. pneumoniae isolates (P <0.001). The type 1 fimbriae, encoded by fimA, contrib-
ute to the invasion of bladder cells and biofilm formation. Despite the low frequency of the
fimA gene in the carbapenem-resistant isolates, these strains were capable of high biofilm
production.
In this study, we confirmed that biofilm production is higher in the carbapenem-resistant
isolates than in the carbapenem-susceptible isolates as previously reported [8], and the pres-
ence of biofilm may contribute to drug resistance. However, more studies are required to
define the impact of virulence genes.
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This studies had several limitations. First, there was a lack of information about the travel of
patients or healthcare workers to places where NDM-1-producing strains are endemic. How-
ever, blaNDM-1 strains been reported in Mexico previously, and the dissemination could be the
result of regional transmission. Another significant limitation of our study is the absence of
analysis of CRE carriers in the hospital. The above limitations could be resolved in future stud-
ies of CRE in this region.
The results obtained in this study indicate that blaNDM-1 was disseminated horizontally
among different species in a tertiary care Hospital in Mexico, also with proof of strain spread
predominantly of K. pneumoniae ST392. We have provided evidence of plasmid transfer but,
given the variation in plasmid sizes, complex rearrangements must also be occurring. In this
analysis, the presence of other carbapenemase genes encoding blaVIM, blaKPC and blaIMP were
sporadic.
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